hmr 1766 has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbosa-Sicard, E; Bauersachs, J; Ertl, G; Fleming, I; Fraccarollo, D; Galuppo, P; Pfrang, J; Ruetten, H; Schäfer, A; Tas, P; Vogt, C; Widder, JD | 1 |
| Bauersachs, J; Eigenthaler, M; Ertl, G; Flierl, U; Kobsar, A; Schäfer, A | 1 |
2 other study(ies) available for hmr 1766 and Alloxan Diabetes
| Article | Year |
|---|---|
Increased cytochrome P4502E1 expression and altered hydroxyeicosatetraenoic acid formation mediate diabetic vascular dysfunction: rescue by guanylyl-cyclase activation.
Topics: Animals; Aorta, Thoracic; Cytochrome P-450 CYP2E1; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Gene Expression Regulation, Enzymologic; Guanylate Cyclase; Humans; Hydroxyeicosatetraenoic Acids; MicroRNAs; Oligonucleotide Array Sequence Analysis; ortho-Aminobenzoates; Oxidative Stress; Rats; Reactive Oxygen Species; Sulfonamides; Superoxides; Up-Regulation; Vasodilation | 2010 |
Soluble guanylyl cyclase activation with HMR1766 attenuates platelet activation in diabetic rats.
Topics: Animals; Blood Platelets; Cell Adhesion Molecules; Cyclic GMP; Diabetes Mellitus, Experimental; Enzyme Activation; Enzyme Activators; Guanylate Cyclase; Male; Microfilament Proteins; Nitric Oxide; ortho-Aminobenzoates; Phosphoproteins; Platelet Activation; Platelet Aggregation; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Soluble Guanylyl Cyclase; Sulfonamides; Thrombosis | 2006 |